Additional variations in groups of genes, such as T-cell receptor (TCR) genes, immunoglobulin (Ig) genes, or myelin basic protein (MBP) genes, contribute to the increasing risk of developing MS [12]. This evidence concerns the gene MBP and myeloid sarcoma.